Skip to main content
OpenTrials
Completed

NCT Number: NCT04257058

Education Tools to Support Pediatric Survivor Care

This study aims to evaluate the impact of electronic educational materials on adolescent and young adult (AYA) survivors' knowledge about late effects, perceived benefits, self-efficacy, and intentions to engage in lifelong survivor care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Healthcare of Atlanta

Atlanta, Georgia, 30322, United States

About this study

Despite increased risk for morbidity and mortality related to cancer treatment, over half of young adult survivors of childhood cancer do not engage in the recommended healthcare designed to detect late effects and secondary cancers. There is a scarcity of data on adherence to survivor-focused healthcare, particularly at the critical transition from pediatrics to adult care. In order to improve transition outcomes, the investigators need to create media to educate survivors about need for adherence to adult survivor healthcare.

This study aims to evaluate the impact of electronic educational materials on AYA survivors' knowledge about late effects, perceived benefits, self-efficacy, and intentions to engage in lifelong survivor care.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients must be 18-25 years of age,
  • Diagnosed with cancer at ≤ 18 years of age,
  • ≥ 2 years since the last cancer treatment,
  • seen at least once in the Aflac Cancer Survivor Program (CSP) in the past 2 years or transitioned out of the Aflac CSP to adult survivor care since 2013.

Exclusion criteria

  • Patients will be excluded from participation in the study if the participant is non-English speaking.
  • Young adult survivors who are cognitively impaired and unable to complete the questionnaires.
  • Participants that do not consent to the recording of their interviews.

Treatment and study plan

Electronic educational material

Behavioral

Electronic media via email

Primary outcomes

  1. Survivor Care Knowledge Scale

    Time frame: Baseline, 2 weeks post-intervention

    Knowledge was assessed at baseline and 2 weeks post-intervention, with the Survivor Care Knowledge scale, that includes 15-item multiple-choice quiz to assess participants' knowledge of the content covered in the electronic educational materials previously provided. Total score ranges from 0-15. Higher score is associated with better outcome.

Secondary outcomes

  1. Benefits for Survivor Care

    Time frame: Baseline, 2 weeks post-intervention

    5-item study adapted Champion Benefits Scale for Mammography Screening. Total score ranges from 5-25. Lower score equals fewer perceived benefits of survivor care.

  2. Barriers for Survivor Care

    Time frame: Baseline, 2 weeks post-intervention

    11-item study adapted Champion Barriers Scale for Mammography Screening. Total score ranges from 11-55. Lower score equals fewer perceived barriers to survivor care.

  3. Perceived Susceptibility for Late Effects

    Time frame: Baseline, 2 weeks post-intervention

    3-item study adapted Champion Susceptibility Scale for Mammography Screening. Total score ranges from 3-15. Lower score equals less susceptibility to late effects of treatment.

  4. Intentions for Survivor Care

    Time frame: Baseline, 2 weeks post-intervention

    2-item study adapted Ajzen's Theory of Planned Behavior- Intentions. Total score ranges from 2-14. Lower score equals greater intention to engage in long-term follow-up care.

  5. Change in Perceived Health Competence Scale (PHCS)

    Time frame: Baseline, 2 weeks post-intervention

    8-item Perceived Health Competence Scale (PHCS). Total score ranges from 8-40. Lower score equals lower perceived health competence.

Sponsors and collaborators

Lead sponsor

Emory University

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Predicting Childhood Cancer Survivors' Transition Readiness & Transfer Outcomes (SURV Transfer Outcomes) (Administrative Supplement to R01CA218389)

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Feb 5, 2020
Registry last updated
May 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.